PATENT CLAIM ANALYSIS

Application Number: 16073620
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "210180"]

Abstract:
A compound represented by general formula (I-1): wherein the symbols are defined in the specification, has a selective S1P 5  receptor binding activity and modulates the function of an S1P5 receptor, and can therefore be a therapeutic agent for a S1P 5 -mediated disease, for example, neurodegenerative diseases such as schizophrenia, Binswanger's disease and the like.

Claim (Index 18):
The compound according to  claim 2 , wherein Z is a carboxyl group which may be substituted with a C1-8 alkyl group, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.32
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14001936', '15034905', '10530249', '15539530', '10488835']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7749079568080621
- 35 USC 102 Novelty (BERT): 0.5335147930607732
- Combined Prediction Score: 0.7507686404333332
- Mean Citation Score: 315.965848
- Max Citation Score: 323.4134200000001
- Similarity Product: 195.09942412825828

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test